Abstract
The present paper examines major evidences on the correlation between pre-diabetes, diabetes and cardiovascular risk, especially focusing on early and multifactorial treatment strategies holding the potential to delay the occurrence of micro- and macro-vascular complications causing impaired quality of life and reduced survival.
MeSH terms
-
Biomarkers / metabolism
-
Blood Glucose / metabolism
-
Cardiovascular Diseases / blood
-
Cardiovascular Diseases / etiology*
-
Cardiovascular Diseases / mortality
-
Cardiovascular Diseases / prevention & control
-
Diabetes Mellitus, Type 2 / blood
-
Diabetes Mellitus, Type 2 / etiology*
-
Diabetes Mellitus, Type 2 / mortality
-
Diabetes Mellitus, Type 2 / therapy
-
Glycated Hemoglobin / metabolism
-
Humans
-
Hypoglycemic Agents / therapeutic use
-
Prediabetic State / blood
-
Prediabetic State / complications*
-
Prediabetic State / mortality
-
Prediabetic State / therapy
-
Prevalence
-
Preventive Health Services
-
Risk Assessment
-
Risk Factors
-
Risk Reduction Behavior
-
Treatment Outcome
Substances
-
Biomarkers
-
Blood Glucose
-
Glycated Hemoglobin A
-
Hypoglycemic Agents
-
hemoglobin A1c protein, human